KR910000165A - 비경구 투여용 fr 115224 물질의 제제 - Google Patents

비경구 투여용 fr 115224 물질의 제제 Download PDF

Info

Publication number
KR910000165A
KR910000165A KR1019900008086A KR900008086A KR910000165A KR 910000165 A KR910000165 A KR 910000165A KR 1019900008086 A KR1019900008086 A KR 1019900008086A KR 900008086 A KR900008086 A KR 900008086A KR 910000165 A KR910000165 A KR 910000165A
Authority
KR
South Korea
Prior art keywords
parenteral administration
preparations
substances
cyclodextrin
formulation
Prior art date
Application number
KR1019900008086A
Other languages
English (en)
Inventor
소루 아사쿠라
노부토 가나가와
유헤이 기요타
Original Assignee
후지사와 토모키치로
후지사와 야쿠힝고교가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지사와 토모키치로, 후지사와 야쿠힝고교가부시키가이샤 filed Critical 후지사와 토모키치로
Publication of KR910000165A publication Critical patent/KR910000165A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

비경구 투여용 FR 115224 물질의 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. FR 115224 물질 및 사이클로덱스트린을 함유하는 비경구 투여용 제제.
  2. 제1항에 있어서, 사이클로덱스트린이 β-사이클로덱스트린이 비경구 투여용 제제.
  3. 제1항 또는 제2항에 있어서, 흡입 조성물인 비경구 투여용 제제.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900008086A 1989-06-02 1990-06-01 비경구 투여용 fr 115224 물질의 제제 KR910000165A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14197289 1989-06-02
JP1-141972 1989-06-02

Publications (1)

Publication Number Publication Date
KR910000165A true KR910000165A (ko) 1991-01-29

Family

ID=15304406

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900008086A KR910000165A (ko) 1989-06-02 1990-06-01 비경구 투여용 fr 115224 물질의 제제

Country Status (11)

Country Link
US (1) US5093127A (ko)
EP (1) EP0400637B1 (ko)
JP (1) JP2987883B2 (ko)
KR (1) KR910000165A (ko)
AT (1) ATE96331T1 (ko)
AU (1) AU644588B2 (ko)
CA (1) CA2017156A1 (ko)
DE (1) DE69004151T2 (ko)
DK (1) DK0400637T3 (ko)
ES (1) ES2059882T3 (ko)
ZA (1) ZA903856B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0498069T3 (da) * 1990-12-21 1995-12-04 Fujisawa Pharmaceutical Co Ny anvendelse af peptidderivat
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
CA2192965C (en) * 1994-07-11 2007-12-04 David W. Pate Anandamide analogue compositions and method of treating intraocular hypertension using same
US5631297A (en) * 1994-07-11 1997-05-20 Pate; David W. Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same
US6123932A (en) * 1999-06-14 2000-09-26 The Procter & Gamble Company Deodorant compositions containing cyclodextrin odor controlling agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB2226023A (en) * 1988-11-29 1990-06-20 Glaxo Group Ltd Optical isomers of thromboxane antagonist prostanoids
GB8807921D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Also Published As

Publication number Publication date
AU644588B2 (en) 1993-12-16
ZA903856B (en) 1991-05-29
ES2059882T3 (es) 1994-11-16
AU5604790A (en) 1990-12-06
DE69004151T2 (de) 1994-03-24
JP2987883B2 (ja) 1999-12-06
ATE96331T1 (de) 1993-11-15
DK0400637T3 (da) 1993-12-06
EP0400637A3 (en) 1991-07-03
EP0400637A2 (en) 1990-12-05
EP0400637B1 (en) 1993-10-27
CA2017156A1 (en) 1990-12-02
JPH0386833A (ja) 1991-04-11
DE69004151D1 (de) 1993-12-02
US5093127A (en) 1992-03-03

Similar Documents

Publication Publication Date Title
AU635358B2 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
SG48788A1 (en) Novel derivatives of y-cyclodextrin
KR900000335A (ko) 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제
KR910000165A (ko) 비경구 투여용 fr 115224 물질의 제제
DE69025691D1 (de) Einschlusskomplexe mit Silybinin, ihre Herstellung und pharmazeutische Präparate, die diese enthalten
KR910021361A (ko) 항궤양 물질
KR910000114A (ko) 멜라닌 생성 억제 외용제
KR870005968A (ko) 아미드 유도체 및 이를 함유하는 외용약제
PT81429B (pt) Processo para a preparacao de formulacoes ou suspensoes estaveis de medicamentos solidos, contendo 4-hidroxi- ou 4-aciloxi-4-androsteno-3,17-dionas
NL169337C (nl) Werkwijze voor de bereiding van vormmassa's van macromoleculaire thermoplastische polycarbonaten, alsmede daarvan vervaardigd gevormd voortbrengsel.
NO178286C (no) Fremgangsmåte ved fremstilling av et topisk farmasöytisk preparat inneholdende 1
KR920019364A (ko) 약학적 화합물
SE9004169D0 (sv) Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel
KR920011500A (ko) 느릅나무 추출물을 함유하는 항종양 조성물
KR910000115A (ko) 멜라닌 생성 억제 외용제
KR890009386A (ko) 백금화합물 동결건조제제
KR910000106A (ko) 발모촉진제
KR920701221A (ko) 신규한 백금 착체 및 이를 유효성분으로 하는 항종양제
KR930000109A (ko) 참. 존
KR890001556A (ko) 약제학적 조성물
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
KR900012622A (ko) 피부질환치료 조성물
KR890007747A (ko) 약쑥과 한방 생약성분이 함유된 피부미용 스킨
KR890017649A (ko) 조소재료(彫塑材料)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid